Global Orexin Receptor Antagonists Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
Orexin receptor antagonists are the type of therapeutics used in the treatment of sleep disorders, characterized by difficulties or problems with sleep onset. It either bind or inhibits the action of orexin receptor. Orexin plays a vital role in the sleep–wake cycle through a complex interplay between the monoaminergic/cholinergic (wake-promoting) and gamma-aminobutyric acidergic (sleep-promoting) neuronal systems.
The global market for Orexin Receptor Antagonists is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Orexin Receptor Antagonists market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Orexin Receptor Antagonists market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Orexin Receptor Antagonists market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Orexin Receptor Antagonists market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Orexin Receptor Antagonists players cover Eisai Co., Ltd, Sun Pharmaceutical Industries Ltd, Novartis AG, Endo Pharmaceuticals plc and Mylan NV, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Orexin Receptor Antagonists market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Orexin Receptor Antagonists market, with both quantitative and qualitative data, to help readers understand how the Orexin Receptor Antagonists market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Orexin Receptor Antagonists market and forecasts the market size by Type (Oral and Parenteral,), by Application (Insomnia, Anxious and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Orexin Receptor Antagonists, Research Methodology, etc.
Chapter 2: Executive Summary, global Orexin Receptor Antagonists market size (sales and revenue) and CAGR, Orexin Receptor Antagonists market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Orexin Receptor Antagonists sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Orexin Receptor Antagonists sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Orexin Receptor Antagonists market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Eisai Co., Ltd, Sun Pharmaceutical Industries Ltd, Novartis AG, Endo Pharmaceuticals plc, Mylan NV, Mayne Pharma Group Limited, Teva Pharmaceutical Industries Ltd, Amneal Pharmaceuticals Inc and Merck KGaA, etc.
Chapter 14: Research Findings and Conclusion
Orexin receptor antagonists are the type of therapeutics used in the treatment of sleep disorders, characterized by difficulties or problems with sleep onset. It either bind or inhibits the action of orexin receptor. Orexin plays a vital role in the sleep–wake cycle through a complex interplay between the monoaminergic/cholinergic (wake-promoting) and gamma-aminobutyric acidergic (sleep-promoting) neuronal systems.
The global market for Orexin Receptor Antagonists is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Orexin Receptor Antagonists market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Orexin Receptor Antagonists market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Orexin Receptor Antagonists market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Orexin Receptor Antagonists market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Orexin Receptor Antagonists players cover Eisai Co., Ltd, Sun Pharmaceutical Industries Ltd, Novartis AG, Endo Pharmaceuticals plc and Mylan NV, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Orexin Receptor Antagonists market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Orexin Receptor Antagonists market, with both quantitative and qualitative data, to help readers understand how the Orexin Receptor Antagonists market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Orexin Receptor Antagonists market and forecasts the market size by Type (Oral and Parenteral,), by Application (Insomnia, Anxious and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Oral
- Parenteral
- Insomnia
- Anxious
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eisai Co., Ltd
- Sun Pharmaceutical Industries Ltd
- Novartis AG
- Endo Pharmaceuticals plc
- Mylan NV
- Mayne Pharma Group Limited
- Teva Pharmaceutical Industries Ltd
- Amneal Pharmaceuticals Inc
- Merck KGaA
- Sanofi
- Currax Pharmaceuticals LLC
Chapter 1: Scope of Orexin Receptor Antagonists, Research Methodology, etc.
Chapter 2: Executive Summary, global Orexin Receptor Antagonists market size (sales and revenue) and CAGR, Orexin Receptor Antagonists market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Orexin Receptor Antagonists sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Orexin Receptor Antagonists sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Orexin Receptor Antagonists market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Eisai Co., Ltd, Sun Pharmaceutical Industries Ltd, Novartis AG, Endo Pharmaceuticals plc, Mylan NV, Mayne Pharma Group Limited, Teva Pharmaceutical Industries Ltd, Amneal Pharmaceuticals Inc and Merck KGaA, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Orexin Receptor Antagonists Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Orexin Receptor Antagonists by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Orexin Receptor Antagonists by Country/Region, 2017, 2022 & 2028
2.2 Orexin Receptor Antagonists Segment by Type
2.2.1 Oral
2.2.2 Parenteral
2.3 Orexin Receptor Antagonists Sales by Type
2.3.1 Global Orexin Receptor Antagonists Sales Market Share by Type (2017-2022)
2.3.2 Global Orexin Receptor Antagonists Revenue and Market Share by Type (2017-2022)
2.3.3 Global Orexin Receptor Antagonists Sale Price by Type (2017-2022)
2.4 Orexin Receptor Antagonists Segment by Application
2.4.1 Insomnia
2.4.2 Anxious
2.4.3 Other
2.5 Orexin Receptor Antagonists Sales by Application
2.5.1 Global Orexin Receptor Antagonists Sale Market Share by Application (2017-2022)
2.5.2 Global Orexin Receptor Antagonists Revenue and Market Share by Application (2017-2022)
2.5.3 Global Orexin Receptor Antagonists Sale Price by Application (2017-2022)
3 GLOBAL OREXIN RECEPTOR ANTAGONISTS BY COMPANY
3.1 Global Orexin Receptor Antagonists Breakdown Data by Company
3.1.1 Global Orexin Receptor Antagonists Annual Sales by Company (2020-2022)
3.1.2 Global Orexin Receptor Antagonists Sales Market Share by Company (2020-2022)
3.2 Global Orexin Receptor Antagonists Annual Revenue by Company (2020-2022)
3.2.1 Global Orexin Receptor Antagonists Revenue by Company (2020-2022)
3.2.2 Global Orexin Receptor Antagonists Revenue Market Share by Company (2020-2022)
3.3 Global Orexin Receptor Antagonists Sale Price by Company
3.4 Key Manufacturers Orexin Receptor Antagonists Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Orexin Receptor Antagonists Product Location Distribution
3.4.2 Players Orexin Receptor Antagonists Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OREXIN RECEPTOR ANTAGONISTS BY GEOGRAPHIC REGION
4.1 World Historic Orexin Receptor Antagonists Market Size by Geographic Region (2017-2022)
4.1.1 Global Orexin Receptor Antagonists Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Orexin Receptor Antagonists Annual Revenue by Geographic Region
4.2 World Historic Orexin Receptor Antagonists Market Size by Country/Region (2017-2022)
4.2.1 Global Orexin Receptor Antagonists Annual Sales by Country/Region (2017-2022)
4.2.2 Global Orexin Receptor Antagonists Annual Revenue by Country/Region
4.3 Americas Orexin Receptor Antagonists Sales Growth
4.4 APAC Orexin Receptor Antagonists Sales Growth
4.5 Europe Orexin Receptor Antagonists Sales Growth
4.6 Middle East & Africa Orexin Receptor Antagonists Sales Growth
5 AMERICAS
5.1 Americas Orexin Receptor Antagonists Sales by Country
5.1.1 Americas Orexin Receptor Antagonists Sales by Country (2017-2022)
5.1.2 Americas Orexin Receptor Antagonists Revenue by Country (2017-2022)
5.2 Americas Orexin Receptor Antagonists Sales by Type
5.3 Americas Orexin Receptor Antagonists Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Orexin Receptor Antagonists Sales by Region
6.1.1 APAC Orexin Receptor Antagonists Sales by Region (2017-2022)
6.1.2 APAC Orexin Receptor Antagonists Revenue by Region (2017-2022)
6.2 APAC Orexin Receptor Antagonists Sales by Type
6.3 APAC Orexin Receptor Antagonists Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Orexin Receptor Antagonists by Country
7.1.1 Europe Orexin Receptor Antagonists Sales by Country (2017-2022)
7.1.2 Europe Orexin Receptor Antagonists Revenue by Country (2017-2022)
7.2 Europe Orexin Receptor Antagonists Sales by Type
7.3 Europe Orexin Receptor Antagonists Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Orexin Receptor Antagonists by Country
8.1.1 Middle East & Africa Orexin Receptor Antagonists Sales by Country (2017-2022)
8.1.2 Middle East & Africa Orexin Receptor Antagonists Revenue by Country (2017-2022)
8.2 Middle East & Africa Orexin Receptor Antagonists Sales by Type
8.3 Middle East & Africa Orexin Receptor Antagonists Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Orexin Receptor Antagonists
10.3 Manufacturing Process Analysis of Orexin Receptor Antagonists
10.4 Industry Chain Structure of Orexin Receptor Antagonists
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Orexin Receptor Antagonists Distributors
11.3 Orexin Receptor Antagonists Customer
12 WORLD FORECAST REVIEW FOR OREXIN RECEPTOR ANTAGONISTS BY GEOGRAPHIC REGION
12.1 Global Orexin Receptor Antagonists Market Size Forecast by Region
12.1.1 Global Orexin Receptor Antagonists Forecast by Region (2023-2028)
12.1.2 Global Orexin Receptor Antagonists Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Orexin Receptor Antagonists Forecast by Type
12.7 Global Orexin Receptor Antagonists Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eisai Co., Ltd
13.1.1 Eisai Co., Ltd Company Information
13.1.2 Eisai Co., Ltd Orexin Receptor Antagonists Product Offered
13.1.3 Eisai Co., Ltd Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eisai Co., Ltd Main Business Overview
13.1.5 Eisai Co., Ltd Latest Developments
13.2 Sun Pharmaceutical Industries Ltd
13.2.1 Sun Pharmaceutical Industries Ltd Company Information
13.2.2 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Offered
13.2.3 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sun Pharmaceutical Industries Ltd Main Business Overview
13.2.5 Sun Pharmaceutical Industries Ltd Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Orexin Receptor Antagonists Product Offered
13.3.3 Novartis AG Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Endo Pharmaceuticals plc
13.4.1 Endo Pharmaceuticals plc Company Information
13.4.2 Endo Pharmaceuticals plc Orexin Receptor Antagonists Product Offered
13.4.3 Endo Pharmaceuticals plc Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Endo Pharmaceuticals plc Main Business Overview
13.4.5 Endo Pharmaceuticals plc Latest Developments
13.5 Mylan NV
13.5.1 Mylan NV Company Information
13.5.2 Mylan NV Orexin Receptor Antagonists Product Offered
13.5.3 Mylan NV Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mylan NV Main Business Overview
13.5.5 Mylan NV Latest Developments
13.6 Mayne Pharma Group Limited
13.6.1 Mayne Pharma Group Limited Company Information
13.6.2 Mayne Pharma Group Limited Orexin Receptor Antagonists Product Offered
13.6.3 Mayne Pharma Group Limited Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Mayne Pharma Group Limited Main Business Overview
13.6.5 Mayne Pharma Group Limited Latest Developments
13.7 Teva Pharmaceutical Industries Ltd
13.7.1 Teva Pharmaceutical Industries Ltd Company Information
13.7.2 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Offered
13.7.3 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.8 Amneal Pharmaceuticals Inc
13.8.1 Amneal Pharmaceuticals Inc Company Information
13.8.2 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product Offered
13.8.3 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Amneal Pharmaceuticals Inc Main Business Overview
13.8.5 Amneal Pharmaceuticals Inc Latest Developments
13.9 Merck KGaA
13.9.1 Merck KGaA Company Information
13.9.2 Merck KGaA Orexin Receptor Antagonists Product Offered
13.9.3 Merck KGaA Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Merck KGaA Main Business Overview
13.9.5 Merck KGaA Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Orexin Receptor Antagonists Product Offered
13.10.3 Sanofi Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Currax Pharmaceuticals LLC
13.11.1 Currax Pharmaceuticals LLC Company Information
13.11.2 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product Offered
13.11.3 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Currax Pharmaceuticals LLC Main Business Overview
13.11.5 Currax Pharmaceuticals LLC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Orexin Receptor Antagonists Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Orexin Receptor Antagonists by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Orexin Receptor Antagonists by Country/Region, 2017, 2022 & 2028
2.2 Orexin Receptor Antagonists Segment by Type
2.2.1 Oral
2.2.2 Parenteral
2.3 Orexin Receptor Antagonists Sales by Type
2.3.1 Global Orexin Receptor Antagonists Sales Market Share by Type (2017-2022)
2.3.2 Global Orexin Receptor Antagonists Revenue and Market Share by Type (2017-2022)
2.3.3 Global Orexin Receptor Antagonists Sale Price by Type (2017-2022)
2.4 Orexin Receptor Antagonists Segment by Application
2.4.1 Insomnia
2.4.2 Anxious
2.4.3 Other
2.5 Orexin Receptor Antagonists Sales by Application
2.5.1 Global Orexin Receptor Antagonists Sale Market Share by Application (2017-2022)
2.5.2 Global Orexin Receptor Antagonists Revenue and Market Share by Application (2017-2022)
2.5.3 Global Orexin Receptor Antagonists Sale Price by Application (2017-2022)
3 GLOBAL OREXIN RECEPTOR ANTAGONISTS BY COMPANY
3.1 Global Orexin Receptor Antagonists Breakdown Data by Company
3.1.1 Global Orexin Receptor Antagonists Annual Sales by Company (2020-2022)
3.1.2 Global Orexin Receptor Antagonists Sales Market Share by Company (2020-2022)
3.2 Global Orexin Receptor Antagonists Annual Revenue by Company (2020-2022)
3.2.1 Global Orexin Receptor Antagonists Revenue by Company (2020-2022)
3.2.2 Global Orexin Receptor Antagonists Revenue Market Share by Company (2020-2022)
3.3 Global Orexin Receptor Antagonists Sale Price by Company
3.4 Key Manufacturers Orexin Receptor Antagonists Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Orexin Receptor Antagonists Product Location Distribution
3.4.2 Players Orexin Receptor Antagonists Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OREXIN RECEPTOR ANTAGONISTS BY GEOGRAPHIC REGION
4.1 World Historic Orexin Receptor Antagonists Market Size by Geographic Region (2017-2022)
4.1.1 Global Orexin Receptor Antagonists Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Orexin Receptor Antagonists Annual Revenue by Geographic Region
4.2 World Historic Orexin Receptor Antagonists Market Size by Country/Region (2017-2022)
4.2.1 Global Orexin Receptor Antagonists Annual Sales by Country/Region (2017-2022)
4.2.2 Global Orexin Receptor Antagonists Annual Revenue by Country/Region
4.3 Americas Orexin Receptor Antagonists Sales Growth
4.4 APAC Orexin Receptor Antagonists Sales Growth
4.5 Europe Orexin Receptor Antagonists Sales Growth
4.6 Middle East & Africa Orexin Receptor Antagonists Sales Growth
5 AMERICAS
5.1 Americas Orexin Receptor Antagonists Sales by Country
5.1.1 Americas Orexin Receptor Antagonists Sales by Country (2017-2022)
5.1.2 Americas Orexin Receptor Antagonists Revenue by Country (2017-2022)
5.2 Americas Orexin Receptor Antagonists Sales by Type
5.3 Americas Orexin Receptor Antagonists Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Orexin Receptor Antagonists Sales by Region
6.1.1 APAC Orexin Receptor Antagonists Sales by Region (2017-2022)
6.1.2 APAC Orexin Receptor Antagonists Revenue by Region (2017-2022)
6.2 APAC Orexin Receptor Antagonists Sales by Type
6.3 APAC Orexin Receptor Antagonists Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Orexin Receptor Antagonists by Country
7.1.1 Europe Orexin Receptor Antagonists Sales by Country (2017-2022)
7.1.2 Europe Orexin Receptor Antagonists Revenue by Country (2017-2022)
7.2 Europe Orexin Receptor Antagonists Sales by Type
7.3 Europe Orexin Receptor Antagonists Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Orexin Receptor Antagonists by Country
8.1.1 Middle East & Africa Orexin Receptor Antagonists Sales by Country (2017-2022)
8.1.2 Middle East & Africa Orexin Receptor Antagonists Revenue by Country (2017-2022)
8.2 Middle East & Africa Orexin Receptor Antagonists Sales by Type
8.3 Middle East & Africa Orexin Receptor Antagonists Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Orexin Receptor Antagonists
10.3 Manufacturing Process Analysis of Orexin Receptor Antagonists
10.4 Industry Chain Structure of Orexin Receptor Antagonists
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Orexin Receptor Antagonists Distributors
11.3 Orexin Receptor Antagonists Customer
12 WORLD FORECAST REVIEW FOR OREXIN RECEPTOR ANTAGONISTS BY GEOGRAPHIC REGION
12.1 Global Orexin Receptor Antagonists Market Size Forecast by Region
12.1.1 Global Orexin Receptor Antagonists Forecast by Region (2023-2028)
12.1.2 Global Orexin Receptor Antagonists Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Orexin Receptor Antagonists Forecast by Type
12.7 Global Orexin Receptor Antagonists Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eisai Co., Ltd
13.1.1 Eisai Co., Ltd Company Information
13.1.2 Eisai Co., Ltd Orexin Receptor Antagonists Product Offered
13.1.3 Eisai Co., Ltd Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eisai Co., Ltd Main Business Overview
13.1.5 Eisai Co., Ltd Latest Developments
13.2 Sun Pharmaceutical Industries Ltd
13.2.1 Sun Pharmaceutical Industries Ltd Company Information
13.2.2 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Offered
13.2.3 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sun Pharmaceutical Industries Ltd Main Business Overview
13.2.5 Sun Pharmaceutical Industries Ltd Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Orexin Receptor Antagonists Product Offered
13.3.3 Novartis AG Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Endo Pharmaceuticals plc
13.4.1 Endo Pharmaceuticals plc Company Information
13.4.2 Endo Pharmaceuticals plc Orexin Receptor Antagonists Product Offered
13.4.3 Endo Pharmaceuticals plc Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Endo Pharmaceuticals plc Main Business Overview
13.4.5 Endo Pharmaceuticals plc Latest Developments
13.5 Mylan NV
13.5.1 Mylan NV Company Information
13.5.2 Mylan NV Orexin Receptor Antagonists Product Offered
13.5.3 Mylan NV Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mylan NV Main Business Overview
13.5.5 Mylan NV Latest Developments
13.6 Mayne Pharma Group Limited
13.6.1 Mayne Pharma Group Limited Company Information
13.6.2 Mayne Pharma Group Limited Orexin Receptor Antagonists Product Offered
13.6.3 Mayne Pharma Group Limited Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Mayne Pharma Group Limited Main Business Overview
13.6.5 Mayne Pharma Group Limited Latest Developments
13.7 Teva Pharmaceutical Industries Ltd
13.7.1 Teva Pharmaceutical Industries Ltd Company Information
13.7.2 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Offered
13.7.3 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.8 Amneal Pharmaceuticals Inc
13.8.1 Amneal Pharmaceuticals Inc Company Information
13.8.2 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product Offered
13.8.3 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Amneal Pharmaceuticals Inc Main Business Overview
13.8.5 Amneal Pharmaceuticals Inc Latest Developments
13.9 Merck KGaA
13.9.1 Merck KGaA Company Information
13.9.2 Merck KGaA Orexin Receptor Antagonists Product Offered
13.9.3 Merck KGaA Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Merck KGaA Main Business Overview
13.9.5 Merck KGaA Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Orexin Receptor Antagonists Product Offered
13.10.3 Sanofi Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Currax Pharmaceuticals LLC
13.11.1 Currax Pharmaceuticals LLC Company Information
13.11.2 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product Offered
13.11.3 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Currax Pharmaceuticals LLC Main Business Overview
13.11.5 Currax Pharmaceuticals LLC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Orexin Receptor Antagonists Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Orexin Receptor Antagonists Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Parenteral
Table 5. Global Orexin Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 6. Global Orexin Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 7. Global Orexin Receptor Antagonists Revenue by Type (2017-2022) & ($ million)
Table 8. Global Orexin Receptor Antagonists Revenue Market Share by Type (2017-2022)
Table 9. Global Orexin Receptor Antagonists Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Orexin Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 11. Global Orexin Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 12. Global Orexin Receptor Antagonists Revenue by Application (2017-2022)
Table 13. Global Orexin Receptor Antagonists Revenue Market Share by Application (2017-2022)
Table 14. Global Orexin Receptor Antagonists Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Orexin Receptor Antagonists Sales by Company (2020-2022) & (K Units)
Table 16. Global Orexin Receptor Antagonists Sales Market Share by Company (2020-2022)
Table 17. Global Orexin Receptor Antagonists Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Orexin Receptor Antagonists Revenue Market Share by Company (2020-2022)
Table 19. Global Orexin Receptor Antagonists Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Orexin Receptor Antagonists Producing Area Distribution and Sales Area
Table 21. Players Orexin Receptor Antagonists Products Offered
Table 22. Orexin Receptor Antagonists Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Orexin Receptor Antagonists Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Orexin Receptor Antagonists Sales Market Share Geographic Region (2017-2022)
Table 27. Global Orexin Receptor Antagonists Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Orexin Receptor Antagonists Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Orexin Receptor Antagonists Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Orexin Receptor Antagonists Sales Market Share by Country/Region (2017-2022)
Table 31. Global Orexin Receptor Antagonists Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Orexin Receptor Antagonists Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Orexin Receptor Antagonists Sales by Country (2017-2022) & (K Units)
Table 34. Americas Orexin Receptor Antagonists Sales Market Share by Country (2017-2022)
Table 35. Americas Orexin Receptor Antagonists Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Orexin Receptor Antagonists Revenue Market Share by Country (2017-2022)
Table 37. Americas Orexin Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 38. Americas Orexin Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 39. Americas Orexin Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 40. Americas Orexin Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 41. APAC Orexin Receptor Antagonists Sales by Region (2017-2022) & (K Units)
Table 42. APAC Orexin Receptor Antagonists Sales Market Share by Region (2017-2022)
Table 43. APAC Orexin Receptor Antagonists Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Orexin Receptor Antagonists Revenue Market Share by Region (2017-2022)
Table 45. APAC Orexin Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 46. APAC Orexin Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 47. APAC Orexin Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 48. APAC Orexin Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 49. Europe Orexin Receptor Antagonists Sales by Country (2017-2022) & (K Units)
Table 50. Europe Orexin Receptor Antagonists Sales Market Share by Country (2017-2022)
Table 51. Europe Orexin Receptor Antagonists Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Orexin Receptor Antagonists Revenue Market Share by Country (2017-2022)
Table 53. Europe Orexin Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 54. Europe Orexin Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 55. Europe Orexin Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 56. Europe Orexin Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Orexin Receptor Antagonists Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Orexin Receptor Antagonists Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Orexin Receptor Antagonists Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Orexin Receptor Antagonists Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Orexin Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Orexin Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Orexin Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Orexin Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Orexin Receptor Antagonists
Table 66. Key Market Challenges & Risks of Orexin Receptor Antagonists
Table 67. Key Industry Trends of Orexin Receptor Antagonists
Table 68. Orexin Receptor Antagonists Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Orexin Receptor Antagonists Distributors List
Table 71. Orexin Receptor Antagonists Customer List
Table 72. Global Orexin Receptor Antagonists Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Orexin Receptor Antagonists Sales Market Forecast by Region
Table 74. Global Orexin Receptor Antagonists Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Orexin Receptor Antagonists Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Orexin Receptor Antagonists Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Orexin Receptor Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Orexin Receptor Antagonists Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Orexin Receptor Antagonists Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Orexin Receptor Antagonists Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Orexin Receptor Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Orexin Receptor Antagonists Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Orexin Receptor Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Orexin Receptor Antagonists Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Orexin Receptor Antagonists Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Orexin Receptor Antagonists Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Orexin Receptor Antagonists Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Orexin Receptor Antagonists Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Orexin Receptor Antagonists Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Orexin Receptor Antagonists Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Orexin Receptor Antagonists Revenue Market Share Forecast by Application (2023-2028)
Table 92. Eisai Co., Ltd Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 93. Eisai Co., Ltd Orexin Receptor Antagonists Product Offered
Table 94. Eisai Co., Ltd Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Eisai Co., Ltd Main Business
Table 96. Eisai Co., Ltd Latest Developments
Table 97. Sun Pharmaceutical Industries Ltd Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 98. Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Offered
Table 99. Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sun Pharmaceutical Industries Ltd Main Business
Table 101. Sun Pharmaceutical Industries Ltd Latest Developments
Table 102. Novartis AG Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 103. Novartis AG Orexin Receptor Antagonists Product Offered
Table 104. Novartis AG Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Novartis AG Main Business
Table 106. Novartis AG Latest Developments
Table 107. Endo Pharmaceuticals plc Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 108. Endo Pharmaceuticals plc Orexin Receptor Antagonists Product Offered
Table 109. Endo Pharmaceuticals plc Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Endo Pharmaceuticals plc Main Business
Table 111. Endo Pharmaceuticals plc Latest Developments
Table 112. Mylan NV Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 113. Mylan NV Orexin Receptor Antagonists Product Offered
Table 114. Mylan NV Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Mylan NV Main Business
Table 116. Mylan NV Latest Developments
Table 117. Mayne Pharma Group Limited Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 118. Mayne Pharma Group Limited Orexin Receptor Antagonists Product Offered
Table 119. Mayne Pharma Group Limited Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Mayne Pharma Group Limited Main Business
Table 121. Mayne Pharma Group Limited Latest Developments
Table 122. Teva Pharmaceutical Industries Ltd Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 123. Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Offered
Table 124. Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Teva Pharmaceutical Industries Ltd Main Business
Table 126. Teva Pharmaceutical Industries Ltd Latest Developments
Table 127. Amneal Pharmaceuticals Inc Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 128. Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product Offered
Table 129. Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Amneal Pharmaceuticals Inc Main Business
Table 131. Amneal Pharmaceuticals Inc Latest Developments
Table 132. Merck KGaA Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 133. Merck KGaA Orexin Receptor Antagonists Product Offered
Table 134. Merck KGaA Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Merck KGaA Main Business
Table 136. Merck KGaA Latest Developments
Table 137. Sanofi Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 138. Sanofi Orexin Receptor Antagonists Product Offered
Table 139. Sanofi Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Sanofi Main Business
Table 141. Sanofi Latest Developments
Table 142. Currax Pharmaceuticals LLC Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 143. Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product Offered
Table 144. Currax Pharmaceuticals LLC Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Currax Pharmaceuticals LLC Main Business
Table 146. Currax Pharmaceuticals LLC Latest Developments
Table 1. Orexin Receptor Antagonists Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Orexin Receptor Antagonists Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Parenteral
Table 5. Global Orexin Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 6. Global Orexin Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 7. Global Orexin Receptor Antagonists Revenue by Type (2017-2022) & ($ million)
Table 8. Global Orexin Receptor Antagonists Revenue Market Share by Type (2017-2022)
Table 9. Global Orexin Receptor Antagonists Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Orexin Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 11. Global Orexin Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 12. Global Orexin Receptor Antagonists Revenue by Application (2017-2022)
Table 13. Global Orexin Receptor Antagonists Revenue Market Share by Application (2017-2022)
Table 14. Global Orexin Receptor Antagonists Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Orexin Receptor Antagonists Sales by Company (2020-2022) & (K Units)
Table 16. Global Orexin Receptor Antagonists Sales Market Share by Company (2020-2022)
Table 17. Global Orexin Receptor Antagonists Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Orexin Receptor Antagonists Revenue Market Share by Company (2020-2022)
Table 19. Global Orexin Receptor Antagonists Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Orexin Receptor Antagonists Producing Area Distribution and Sales Area
Table 21. Players Orexin Receptor Antagonists Products Offered
Table 22. Orexin Receptor Antagonists Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Orexin Receptor Antagonists Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Orexin Receptor Antagonists Sales Market Share Geographic Region (2017-2022)
Table 27. Global Orexin Receptor Antagonists Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Orexin Receptor Antagonists Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Orexin Receptor Antagonists Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Orexin Receptor Antagonists Sales Market Share by Country/Region (2017-2022)
Table 31. Global Orexin Receptor Antagonists Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Orexin Receptor Antagonists Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Orexin Receptor Antagonists Sales by Country (2017-2022) & (K Units)
Table 34. Americas Orexin Receptor Antagonists Sales Market Share by Country (2017-2022)
Table 35. Americas Orexin Receptor Antagonists Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Orexin Receptor Antagonists Revenue Market Share by Country (2017-2022)
Table 37. Americas Orexin Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 38. Americas Orexin Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 39. Americas Orexin Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 40. Americas Orexin Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 41. APAC Orexin Receptor Antagonists Sales by Region (2017-2022) & (K Units)
Table 42. APAC Orexin Receptor Antagonists Sales Market Share by Region (2017-2022)
Table 43. APAC Orexin Receptor Antagonists Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Orexin Receptor Antagonists Revenue Market Share by Region (2017-2022)
Table 45. APAC Orexin Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 46. APAC Orexin Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 47. APAC Orexin Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 48. APAC Orexin Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 49. Europe Orexin Receptor Antagonists Sales by Country (2017-2022) & (K Units)
Table 50. Europe Orexin Receptor Antagonists Sales Market Share by Country (2017-2022)
Table 51. Europe Orexin Receptor Antagonists Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Orexin Receptor Antagonists Revenue Market Share by Country (2017-2022)
Table 53. Europe Orexin Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 54. Europe Orexin Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 55. Europe Orexin Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 56. Europe Orexin Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Orexin Receptor Antagonists Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Orexin Receptor Antagonists Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Orexin Receptor Antagonists Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Orexin Receptor Antagonists Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Orexin Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Orexin Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Orexin Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Orexin Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Orexin Receptor Antagonists
Table 66. Key Market Challenges & Risks of Orexin Receptor Antagonists
Table 67. Key Industry Trends of Orexin Receptor Antagonists
Table 68. Orexin Receptor Antagonists Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Orexin Receptor Antagonists Distributors List
Table 71. Orexin Receptor Antagonists Customer List
Table 72. Global Orexin Receptor Antagonists Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Orexin Receptor Antagonists Sales Market Forecast by Region
Table 74. Global Orexin Receptor Antagonists Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Orexin Receptor Antagonists Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Orexin Receptor Antagonists Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Orexin Receptor Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Orexin Receptor Antagonists Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Orexin Receptor Antagonists Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Orexin Receptor Antagonists Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Orexin Receptor Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Orexin Receptor Antagonists Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Orexin Receptor Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Orexin Receptor Antagonists Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Orexin Receptor Antagonists Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Orexin Receptor Antagonists Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Orexin Receptor Antagonists Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Orexin Receptor Antagonists Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Orexin Receptor Antagonists Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Orexin Receptor Antagonists Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Orexin Receptor Antagonists Revenue Market Share Forecast by Application (2023-2028)
Table 92. Eisai Co., Ltd Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 93. Eisai Co., Ltd Orexin Receptor Antagonists Product Offered
Table 94. Eisai Co., Ltd Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Eisai Co., Ltd Main Business
Table 96. Eisai Co., Ltd Latest Developments
Table 97. Sun Pharmaceutical Industries Ltd Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 98. Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Offered
Table 99. Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sun Pharmaceutical Industries Ltd Main Business
Table 101. Sun Pharmaceutical Industries Ltd Latest Developments
Table 102. Novartis AG Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 103. Novartis AG Orexin Receptor Antagonists Product Offered
Table 104. Novartis AG Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Novartis AG Main Business
Table 106. Novartis AG Latest Developments
Table 107. Endo Pharmaceuticals plc Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 108. Endo Pharmaceuticals plc Orexin Receptor Antagonists Product Offered
Table 109. Endo Pharmaceuticals plc Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Endo Pharmaceuticals plc Main Business
Table 111. Endo Pharmaceuticals plc Latest Developments
Table 112. Mylan NV Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 113. Mylan NV Orexin Receptor Antagonists Product Offered
Table 114. Mylan NV Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Mylan NV Main Business
Table 116. Mylan NV Latest Developments
Table 117. Mayne Pharma Group Limited Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 118. Mayne Pharma Group Limited Orexin Receptor Antagonists Product Offered
Table 119. Mayne Pharma Group Limited Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Mayne Pharma Group Limited Main Business
Table 121. Mayne Pharma Group Limited Latest Developments
Table 122. Teva Pharmaceutical Industries Ltd Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 123. Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Offered
Table 124. Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Teva Pharmaceutical Industries Ltd Main Business
Table 126. Teva Pharmaceutical Industries Ltd Latest Developments
Table 127. Amneal Pharmaceuticals Inc Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 128. Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product Offered
Table 129. Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Amneal Pharmaceuticals Inc Main Business
Table 131. Amneal Pharmaceuticals Inc Latest Developments
Table 132. Merck KGaA Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 133. Merck KGaA Orexin Receptor Antagonists Product Offered
Table 134. Merck KGaA Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Merck KGaA Main Business
Table 136. Merck KGaA Latest Developments
Table 137. Sanofi Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 138. Sanofi Orexin Receptor Antagonists Product Offered
Table 139. Sanofi Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Sanofi Main Business
Table 141. Sanofi Latest Developments
Table 142. Currax Pharmaceuticals LLC Basic Information, Orexin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 143. Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product Offered
Table 144. Currax Pharmaceuticals LLC Orexin Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Currax Pharmaceuticals LLC Main Business
Table 146. Currax Pharmaceuticals LLC Latest Developments
LIST OF FIGURES
Figure 1. Picture of Orexin Receptor Antagonists
Figure 2. Orexin Receptor Antagonists Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Orexin Receptor Antagonists Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Orexin Receptor Antagonists Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Orexin Receptor Antagonists Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Parenteral
Figure 11. Global Orexin Receptor Antagonists Sales Market Share by Type in 2021
Figure 12. Global Orexin Receptor Antagonists Revenue Market Share by Type (2017-2022)
Figure 13. Orexin Receptor Antagonists Consumed in Insomnia
Figure 14. Global Orexin Receptor Antagonists Market: Insomnia (2017-2022) & (K Units)
Figure 15. Orexin Receptor Antagonists Consumed in Anxious
Figure 16. Global Orexin Receptor Antagonists Market: Anxious (2017-2022) & (K Units)
Figure 17. Orexin Receptor Antagonists Consumed in Other
Figure 18. Global Orexin Receptor Antagonists Market: Other (2017-2022) & (K Units)
Figure 19. Global Orexin Receptor Antagonists Sales Market Share by Application (2017-2022)
Figure 20. Global Orexin Receptor Antagonists Revenue Market Share by Application in 2021
Figure 21. Orexin Receptor Antagonists Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Orexin Receptor Antagonists Revenue Market Share by Company in 2021
Figure 23. Global Orexin Receptor Antagonists Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Orexin Receptor Antagonists Revenue Market Share by Geographic Region in 2021
Figure 25. Global Orexin Receptor Antagonists Sales Market Share by Region (2017-2022)
Figure 26. Global Orexin Receptor Antagonists Revenue Market Share by Country/Region in 2021
Figure 27. Americas Orexin Receptor Antagonists Sales 2017-2022 (K Units)
Figure 28. Americas Orexin Receptor Antagonists Revenue 2017-2022 ($ Millions)
Figure 29. APAC Orexin Receptor Antagonists Sales 2017-2022 (K Units)
Figure 30. APAC Orexin Receptor Antagonists Revenue 2017-2022 ($ Millions)
Figure 31. Europe Orexin Receptor Antagonists Sales 2017-2022 (K Units)
Figure 32. Europe Orexin Receptor Antagonists Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Orexin Receptor Antagonists Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Orexin Receptor Antagonists Revenue 2017-2022 ($ Millions)
Figure 35. Americas Orexin Receptor Antagonists Sales Market Share by Country in 2021
Figure 36. Americas Orexin Receptor Antagonists Revenue Market Share by Country in 2021
Figure 37. United States Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Orexin Receptor Antagonists Sales Market Share by Region in 2021
Figure 42. APAC Orexin Receptor Antagonists Revenue Market Share by Regions in 2021
Figure 43. China Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Orexin Receptor Antagonists Sales Market Share by Country in 2021
Figure 50. Europe Orexin Receptor Antagonists Revenue Market Share by Country in 2021
Figure 51. Germany Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Orexin Receptor Antagonists Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Orexin Receptor Antagonists Revenue Market Share by Country in 2021
Figure 58. Egypt Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Orexin Receptor Antagonists in 2021
Figure 64. Manufacturing Process Analysis of Orexin Receptor Antagonists
Figure 65. Industry Chain Structure of Orexin Receptor Antagonists
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Orexin Receptor Antagonists
Figure 2. Orexin Receptor Antagonists Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Orexin Receptor Antagonists Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Orexin Receptor Antagonists Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Orexin Receptor Antagonists Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Parenteral
Figure 11. Global Orexin Receptor Antagonists Sales Market Share by Type in 2021
Figure 12. Global Orexin Receptor Antagonists Revenue Market Share by Type (2017-2022)
Figure 13. Orexin Receptor Antagonists Consumed in Insomnia
Figure 14. Global Orexin Receptor Antagonists Market: Insomnia (2017-2022) & (K Units)
Figure 15. Orexin Receptor Antagonists Consumed in Anxious
Figure 16. Global Orexin Receptor Antagonists Market: Anxious (2017-2022) & (K Units)
Figure 17. Orexin Receptor Antagonists Consumed in Other
Figure 18. Global Orexin Receptor Antagonists Market: Other (2017-2022) & (K Units)
Figure 19. Global Orexin Receptor Antagonists Sales Market Share by Application (2017-2022)
Figure 20. Global Orexin Receptor Antagonists Revenue Market Share by Application in 2021
Figure 21. Orexin Receptor Antagonists Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Orexin Receptor Antagonists Revenue Market Share by Company in 2021
Figure 23. Global Orexin Receptor Antagonists Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Orexin Receptor Antagonists Revenue Market Share by Geographic Region in 2021
Figure 25. Global Orexin Receptor Antagonists Sales Market Share by Region (2017-2022)
Figure 26. Global Orexin Receptor Antagonists Revenue Market Share by Country/Region in 2021
Figure 27. Americas Orexin Receptor Antagonists Sales 2017-2022 (K Units)
Figure 28. Americas Orexin Receptor Antagonists Revenue 2017-2022 ($ Millions)
Figure 29. APAC Orexin Receptor Antagonists Sales 2017-2022 (K Units)
Figure 30. APAC Orexin Receptor Antagonists Revenue 2017-2022 ($ Millions)
Figure 31. Europe Orexin Receptor Antagonists Sales 2017-2022 (K Units)
Figure 32. Europe Orexin Receptor Antagonists Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Orexin Receptor Antagonists Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Orexin Receptor Antagonists Revenue 2017-2022 ($ Millions)
Figure 35. Americas Orexin Receptor Antagonists Sales Market Share by Country in 2021
Figure 36. Americas Orexin Receptor Antagonists Revenue Market Share by Country in 2021
Figure 37. United States Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Orexin Receptor Antagonists Sales Market Share by Region in 2021
Figure 42. APAC Orexin Receptor Antagonists Revenue Market Share by Regions in 2021
Figure 43. China Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Orexin Receptor Antagonists Sales Market Share by Country in 2021
Figure 50. Europe Orexin Receptor Antagonists Revenue Market Share by Country in 2021
Figure 51. Germany Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Orexin Receptor Antagonists Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Orexin Receptor Antagonists Revenue Market Share by Country in 2021
Figure 58. Egypt Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Orexin Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Orexin Receptor Antagonists in 2021
Figure 64. Manufacturing Process Analysis of Orexin Receptor Antagonists
Figure 65. Industry Chain Structure of Orexin Receptor Antagonists
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
